Citic Jiantou: We are optimistic about the investment opportunities in the pharmaceutical industry in 2025, focusing on the opportunities of new increase and industry integration. Citic Jiantou Securities reported on December 11th that looking forward to 2025, the reform policy in the pharmaceutical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations on the whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.Market News: South Korean President Yin Xiyue may release a recorded public speech.The US dollar just broke through the 7.2700 yuan mark against the offshore RMB, and the latest price was 7.2698 yuan, down 0.10% in the day.
In the first 11 months of the North Stock Exchange, the issuance scale of new shares decreased by nearly 770% year-on-year, and the new shares rose by over 100% on the first day. Statistics show that from January to November, 2024, there were 20 new shares listed on the North Stock Exchange, and the total amount of funds raised was about 4.175 billion yuan, down by nearly 70% year-on-year. The scale of new shares is generally small, and the number of new shares raised less than 200 million yuan accounts for 65% of the total number of new shares. The share price of 70% new shares rose over 100% on the first day of listing. Among them, the share price of Tongguan Mining Construction rose by 731.41% on the first day of listing, and the share prices of Shengye Electric, Keli and Wanyuantong rose by over 300% on the first day. In terms of underwriters, in the first November of 2024, the number of projects underwritten by CITIC Jiantou Securities was the highest, with a total project scale of about 699 million yuan, followed by First Venture Securities and Minsheng Securities. (Xinhua Finance)Han Dongxun, leader of South Korea's ruling party: Yin Xiyue has no intention of stepping down early. On December 12, local time, Han Dongxun, leader of South Korea's ruling party, said that President Yin Xiyue confirmed that he had no intention of stepping down early. Han Dongxun said that people involved in the martial law incident, including the president, should be severely punished, and Yin Xiyue should immediately remove the right to operate state affairs, including the commander-in-chief of the army. In addition, Han Dongxun said that he would vote in favor of the impeachment case, and members of the ruling party should vote on the impeachment case according to their conscience.On the occasion of Yin Xiyue's speech, the increase of KOSPI index in South Korea narrowed to 0.3%, and it rose by 1.1% earlier.
South Korean President Yin Xiyue made a speech to the people on the 12th, accusing the opposition party of framing "the crime of civil strife" and engaging in impeachment. (Xinhua News Agency)Syrian Human Rights Watch: Israel continues to air strike Syrian military facilities. On the 12th local time, Syrian Human Rights Watch said that Israeli warplanes continued to launch air strikes against military facilities in Syria, including military sites in Latakia port and arsenals in Tartus province. According to the organization, this is the fourth consecutive day that Israeli warplanes launched an air strike on the Syrian arsenal after the overthrow of Bashar al-Assad's government.South Korean President Yin Xiyue: The large opposition party has become a monster that undermines order; The opposition is threatening national security and social security.
Strategy guide
12-13
Strategy guide
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13